Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure

Atherosclerosis

Volumn 141, Issue 2, 1998, Pages 249-257

  Hsueh, Yu Mei ^a   Wu, Wen Lin ^a   Huang, Ya Li ^a   Chiou, Hung Yi ^a   Tseng, Chin Hsiao ^b   Chen, Chien Jen ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Ischemic heart disease; Serum carotene level

Indexed keywords

ARSENIC; CAROTENE; WELL WATER;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; FLUID INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN;

ADULT; ALCOHOL DRINKING; ANTIOXIDANTS; ARSENIC; BETA CAROTENE; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; QUESTIONNAIRES; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; TAIWAN; TIME FACTORS; VITAMIN A; VITAMIN E; WATER SUPPLY;

EID: 0032403039     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00178-6     Document Type: Article

References (56)

1. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 19:1977;110-119.
2. Borgono JM, Vincent P, Venturino H, Infante A. Arsenic in the drinking water of the city if Antofagasta: epidemiological and clinical study before and after the installation of the treatment plant. Environ Health Perspect. 19:1977;103-105.
3. Cebrian ME. Some potential problems in assessing the effects of chronic arsenic poisoning in north Mexico. In: Preprints of Papers Presented at the American Chemical Society, Division of Environmental Chemistry, 194th Meeting, New Orleans, 1987:114-116.
4. Chen CJ, Wu MM, Lee SS, Wang JD, Chen SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 8:1988;452-460.
5. Grobe JW. Peripheral circulatory disorders and acrocyanosis with arsenic. Berufs Dermatosen. 24:1976;78-84.
6. Lagerkvist BE, Linderholm H, Nordberg GF. Arsenic and Raynaud's phenomenon: vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int Arch Occup Environ Health. 60:1988;361-364.
7. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 16:1996;504-510.
8. Zaldivar R. A morbid condition involving cardiovascular, bronchopulmonary, digestive and neural lesions in children and young adults after dietary arsenic exposure. Zentralbl Bakteriol. 170:1980;44-56.
9. Tsuda T, Nagira T, Yamamoto M. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health. 28:1990;53-62.
10. Hansen ES. Mortality from cancer and ischemic heart disease in Danish chimney sweeps: a 5-year follow-up. Am J Epidemiol. 117:1983;160-164.
11. Gustavsson P, Gustavsson A, Hogstedt C. Excess mortality among Swedish chimney sweeps. Br J Ind Med. 44:1987;738-743.
12. Axelson O, Dahlgren E, Janssen CD, Rehnlund SO. Arsenic exposure and mortality: a case reference study from a Swedish copper smelter. Br J Ind Med. 35:1978;8-15.
13. Welch K, Higgins I, Oh M, Burchfiel C. Arsenic exposure, smoking, and respiratory cancer in copper smelter smelter workers. Arch Environ Health. 37:1982;325-335.
14. Wingren G, Axelson O. Mortality in the Swedish glassworks industry. Scand J Work Environ Health. 13:1987;412-416.
15. Van Poppel G. Epidemiological evidence for β-carotene in prevention of cancer and cardiovascular disease. Eur J Clin Nutr 1996; 50(suppl 3):S57-S61.
16. Kristenson M, Zieden B, Kucinskiene Z, Elinder LS, Bergdahl B, Elwing B, Abaravicius A, Razinkoviene L, Calkauskas H, Olsson AG. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. Br Med J. 314:1997;629-633.
17. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr. 13:1993;561-587.
18. Bertram JS, Pung A, Churley M, Kappock TJ, Wilkins LR, Cooney RV. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis. 12:1991;671-678.
19. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
20. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl Med. 320:1989;915-924.
21. Andrews B, Burnand K, Paganga G, Browse B, Rice-Evans C, Sommerville K. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis. 112:1995;77-84.
22. Wu HY, Chen KP, Tseng WP, Hsu CL. Epidemiologic studies on blackfoot disease: I. Prevalence and incidence of the disease by age, sex, occupation and geographical distribution. Mem College Med Natl Taiwan Univ. 7:1961;33-50.
23. Kuo TL. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Reports, Institute of Pathology, National Taiwan University 1964; 20:7-13.
24. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 25:1995;53-60.
25. Rose GA, Blackburn H, Gillum RF, Prineas RJ Cardiovascular survey methods. 2nd edition:1982;World Health Organization, Geneva.
26. Miller KW, Lorr NA, Yang CS. Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high performance liquid chromatography. Anal Biochem. 138:1984;340-345.
27. Tseng CH, Chong CK, Chen CJ, Tai TY. Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology. 48:1997;321-335.
28. Yeh SJ, Yang MH. Trace element in water samples from the endemic area of blackfoot disease and biospecimens from blackfoot disease patients: a preliminary report. Blackfoot Dis Res Rep. 8:1980;22-28.
29. Lu FJ. Blackfoot disease: arsenic or humic acid. Lancet. 336:1990;115-116.
30. Chen CJ. Blackfoot disease. Lancet. 336:1990;442.
31. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 139:1994;484-492.
32. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 153:1993;598-615.
33. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MS, Lue LC, Chen GS, Chen CJ. Serum β-carotene, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomark Prev. 6:1997;589-596.
34. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. J Am Med Assoc. 272:1994;1439-1441.
35. Jha P, Flather M, Lonn E, Farkouh M, Yusof S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med. 123:1995;860-872.
36. Kohlmeier L, Hastings SB. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr. 62:1995;1370S-1376.
37. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men. Am J Epidemiol. 142:1995;1269-1278.
38. Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr. 61:1995;670S-677.
39. Gerster H. Potential role of beta-carotene in the prevention of cardiovascular disease. Int J Vitam Nutr Res. 61:1991;277-291.
40. Krinsky NI. Antioxidant functions of cartenoids. Free Radic Biol Med. 7:1989;617-635.
41. Bendich A. Caroteniods and immune response. J Nutr. 119:1989;112-115.
42. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis. 12:1991;2109-2114.
43. Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomark Prev. 3:1994;493-500.
44. National Research Council, Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.
45. Ohrvall M, Sundl of G, Vessby B. Gamma, but not alpha, tocopherol levels in serums are reduced in coronary heart disease patients. J Intern Med. 239:1996;111-117.
46. Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L et al. Antioxidants in adipose tissue and risk of myocardial infarction the EURAMIC study. Lancet. 342:1993;1379-1384.
47. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation. 90:1994;1154-1161.
48. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel prospective study. Clin Invest. 71:1993;3-6.
49. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Coldity GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med. 328:1993;1450-1456.
50. Talwar Dinesh, Ha Tom KK, Scott Hazel R, Cooney Josephine, Fell Gordon S, O'Reilly Denis St, Lean Michael EJ, McMillan Donald C Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer. Am J Clin Nutr. 66:1997;1283-1285.
51. Jialal I, Norkus E, Cristol L, Grundy SM. Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochem Biophys Acta. 1086:1991;134-138.
52. Lavy A, Amotz AB, Aviram M. Preferential inhibition of LDL oxidation by the all-trans isomer of beta-carotene in comparison with 9-cis beta-carotene. Eur J Clin Chem Clin Biochem. 31:1993;83-90.
53. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb. 12:1992;554-562.
54. Reaven PD, Khouw A, Beltz WF, Parthasarthy S, Witztum JJ. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 13:1993;590-600.
55. Khaw Kt, Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. Br Med J. 310:1995;1559-1563.
56. Stamler J, Ruth KJ, Liu K, Shekkele RB. Dietary antioxidants and blood pressure change in the western electric study (abstract). 34th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. Tampa, Florida, 1993.